Bhang or Bangi saved the life of a little girl called Charlotte Figi from Colorado, USA. Her parents had tried every possible conventional remedy prescribed by doctors to treat the more than 300 seizures she was experiencing every day.
Nothing worked. But bangi did. Charlotte was not 100 percent cured, but her seizures reduced from thousands a week to just about two in seven days, as captured in CNN’s Dr Sanjay Gupta’s documentary, Weed. Isn’t that remarkable?
The World Health Organization has declared that CBD – the relaxant property of cannabis used in medical marijuana – should not be a scheduled drug.
As legalization of cannabis has spread rapidly across the United States and around the world, health officials have cautioned that we do not have enough research to rule out any downsides.
But today, after months of deliberation and investigation, the WHO has concluded that cannabidiol (CBD) is a useful treatment for epilepsy and palliative care, and does not carry any addiction risks.
While the organization is set to run a fuller review of cannabis next year, assessing all cannabis-related substances, physicians and the cannabis industry have been poised awaiting this decision to deny scheduling for months.